Scarica l'app Stockscreener
7.58
6.19%
-0.50
Dopo l'orario di chiusura:
7.58
Precedente Chiudi:
$8.08
Aprire:
$8.06
Volume 24 ore:
70,184
Relative Volume:
0.49
Capitalizzazione di mercato:
$730.05M
Reddito:
$106.66M
Utile/perdita netta:
$15.16M
Rapporto P/E:
81.07
EPS:
0.0935
Flusso di cassa netto:
$6.37M
1 W Prestazione:
-8.45%
1M Prestazione:
+7.98%
6M Prestazione:
-30.46%
1 anno Prestazione:
-38.67%
Intervallo 1D:
$7.46
$8.06
Intervallo di 1 settimana:
$7.02
$8.40
Portata 52W:
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Nome
Gyre Therapeutics Inc
Settore
Industria
Telefono
(619) 949-3681
Indirizzo
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Confronta GYRE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.58 | 700.27M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-26 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-11 | Iniziato | Noble Capital Markets | Outperform |
| 2021-04-29 | Ripresa | Stephens | Overweight |
| 2021-02-10 | Iniziato | Piper Sandler | Overweight |
| 2020-05-21 | Iniziato | Raymond James | Outperform |
| 2019-01-04 | Iniziato | Oppenheimer | Outperform |
| 2018-02-12 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Reiterato | Chardan Capital Markets | Buy |
| 2017-12-08 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Iniziato | Chardan Capital Markets | Buy |
| 2017-06-06 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-06-30 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Gyre Therapeutics Inc Borsa (GYRE) Ultime notizie
What is Gyre Therapeutics Inc. s revenue forecastQuarterly Risk Review & Fast Moving Market Watchlists - khodrobank.com
Price action breakdown for Gyre Therapeutics Inc.July 2025 Retail & Safe Swing Trade Setups - Newser
What Fibonacci levels say about Gyre Therapeutics Inc. reboundWeekly Profit Report & Safe Entry Point Identification - Newser
Published on: 2025-09-03 09:00:46 - Newser
How to interpret RSI for Gyre Therapeutics Inc. stock2025 Top Gainers & Verified Momentum Stock Alerts - Newser
Gyre Therapeutics Inc.’s volatility index tracking explainedInflation Watch & Verified Technical Signals - Newser
Can Gyre Therapeutics Inc. stock outperform in a bear marketTrade Exit Summary & Growth Oriented Trading Recommendations - khodrobank.com
Gyre Therapeutics Inc. stock momentum explainedQuarterly Profit Review & Community Consensus Trade Signals - Newser
Live market analysis of Gyre Therapeutics Inc.July 2025 Outlook & Daily Growth Stock Investment Tips - Newser
Is Gyre Therapeutics Inc. benefiting from interest rate changes2025 Macro Impact & Weekly High Return Stock Forecasts - khodrobank.com
Full technical analysis of Gyre Therapeutics Inc. stock2025 Winners & Losers & Technical Entry and Exit Tips - Newser
Custom watchlist performance reports with Gyre Therapeutics Inc.2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser
Will a bounce in Gyre Therapeutics Inc. offer an exitQuarterly Trade Review & AI Driven Stock Movement Reports - Newser
Predicting Gyre Therapeutics Inc. trend using moving averagesTrade Volume Summary & Stock Market Timing Techniques - Newser
Will Gyre Therapeutics Inc. see short term momentumWeekly Market Summary & Expert Approved Momentum Ideas - Newser
Real time scanner hits for Gyre Therapeutics Inc. explained2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Forecasting Gyre Therapeutics Inc. price range with options dataWeekly Investment Report & Verified Stock Trade Ideas - Newser
Will Gyre Therapeutics Inc. benefit from sector rotationJuly 2025 Update & Weekly High Momentum Picks - khodrobank.com
Is Gyre Therapeutics Inc. a defensive stock2025 Dividend Review & AI Based Trade Execution Alerts - khodrobank.com
Published on: 2025-09-02 13:14:36 - Newser
Sell Signal: Can Gyre Therapeutics Inc. reach all time highs this year - khodrobank.com
What is Gyre Therapeutics Inc. s P E ratio telling usWeekly Investment Summary & Long-Term Safe Investment Ideas - خودرو بانک
Can Gyre Therapeutics Inc. recover in the next quarterWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Gyre therapeutics president Ma Songjiang sells $46,360 in stock - MSN
Is it time to cut losses on Gyre Therapeutics Inc.Weekly Profit Analysis & Free Daily Entry Point Trade Alerts - Newser
Is Gyre Therapeutics Inc.’s ROE strong enoughJuly 2025 Movers & Low Risk High Win Rate Stock Picks - khodrobank.com
Using portfolio simulators with Gyre Therapeutics Inc. includedWeekly Profit Analysis & Reliable Entry Point Trade Alerts - Newser
Analyzing drawdowns of Gyre Therapeutics Inc. with statistical tools2025 Performance Recap & Risk Controlled Daily Plans - Newser
Technical analysis overview for Gyre Therapeutics Inc. stockWeekly Gains Summary & High Win Rate Trade Alerts - Newser
Momentum Screeners Rank Gyre Therapeutics Inc. in Top 5 Today getLinesFromResByArray error: size == 0 - thegnnews.com
Can a trend reversal in Gyre Therapeutics Inc. lead to recoveryWeekly Market Summary & Low Drawdown Investment Ideas - Newser
Has Gyre Therapeutics Inc. formed a bullish divergenceQuarterly Portfolio Report & Smart Investment Allocation Insights - Newser
Gyre Therapeutics Inc Azioni (GYRE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Gyre Therapeutics Inc Azioni (GYRE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ma Songjiang | President |
May 28 '25 |
Sale |
10.07 |
558 |
5,619 |
2,806,084 |
| Ma Songjiang | President |
May 22 '25 |
Sale |
10.97 |
2,000 |
21,940 |
2,808,824 |
| Ma Songjiang | President |
May 23 '25 |
Sale |
10.24 |
182 |
1,864 |
2,808,642 |
| Ma Songjiang | President |
May 20 '25 |
Sale |
11.25 |
2,000 |
22,500 |
2,812,824 |
| Ma Songjiang | President |
May 21 '25 |
Sale |
10.83 |
2,000 |
21,660 |
2,810,824 |
| Ma Songjiang | President |
May 16 '25 |
Sale |
11.31 |
2,000 |
22,620 |
2,816,824 |
| Ma Songjiang | President |
May 19 '25 |
Sale |
11.11 |
2,000 |
22,220 |
2,814,824 |
| Ma Songjiang | President |
May 15 '25 |
Sale |
10.68 |
2,000 |
21,360 |
2,818,824 |
| Ma Songjiang | President |
May 14 '25 |
Sale |
11.30 |
20 |
226 |
2,820,824 |
| Ye Weiguo | Chief Operating Officer |
Apr 01 '25 |
Option Exercise |
0.75 |
50,000 |
37,500 |
700,000 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):